Intervention Review

Drug treatment for facioscapulohumeral muscular dystrophy

  1. Michael R Rose1,*,
  2. Rabi Tawil2

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 8 OCT 2008

Assessed as up-to-date: 9 JAN 2004

DOI: 10.1002/14651858.CD002276.pub2

Database Title

Additional Information

How to Cite

Rose MR, Tawil R. Drug treatment for facioscapulohumeral muscular dystrophy. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD002276. DOI: 10.1002/14651858.CD002276.pub2.

Author Information

  1. 1

    King's College Hospital, Department of Neurology, London, UK

  2. 2

    University of Rochester School of Medicine and Dentistry, Neuromuscular Disease Center, Rochester, New York, USA

*Michael R Rose, Department of Neurology, King's College Hospital, Academic Neuroscience Centre, Denmark Hill, London, SE5 9RS, UK. m.r.rose@kcl.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 OCT 2008

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (57K)Standard (180K)Full (220K)

  1. Current Version

    Drug treatment for facioscapulohumeral muscular dystrophy

    Michael R Rose and Rabi Tawil

    Article first published online: 8 OCT 2008 | DOI: 10.1002/14651858.CD002276.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Drug treatment for facioscapulohumeral muscular dystrophy

    R Tawil and MR Rose

    Article first published online: 22 JAN 2000 | DOI: 10.1002/14651858.CD002276

View Full Article (HTML) Summary (57K)Standard (180K)Full (220K)